Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis)

Luca Potestio, Salvatore Corrao, Luca Mastorino, Francesca Maria Gaiani, Emanuele Claudio Cozzani, Martina Maurelli, Nello Tommasino, Stefano Caccavale, Luigi Gargiulo, Carlo Giovanni Carrera, Lidia Sacchelli, Caterina Longo, Sara Marchetti, Alessandra Michelucci, Dario Valguarnera, Andrea Carugno, Simone Mozzato, Francesca Lussana, Lorenzo Mercadante, Luca Cangialosi, Francesco Messina, Eugenia Veronica Di Brizzi, Matteo Bianco, Salvatore Scibetta, Chiara Assorgi, Marco Campoli, Rosa Giuseppa Angileri, Annunziata Dattola, Emanuele Trovato, Maria Esposito, Nicola Zerbinati, Claudio Guarneri, Francesco Loconsole, Valentina Dini, Anna Campanati, Claudia Lasagni, Federico Bardazzi, Angelo Valerio Marzano, Massimo Travaglini, Alessandra Narcisi, Anna Balato, Matteo Megna, Giampiero Girolomoni, Martina Burlando, Piergiorgio Malagoli, Simone Ribero, Diego Orsini

Open source

DOI: 10.1007/s13555-026-01925-5
Published: 2026-09-17
Container: Dermatology and Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01925-5,
  title = {Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis)},
  author = {Luca Potestio and Salvatore Corrao and Luca Mastorino and Francesca Maria Gaiani and Emanuele Claudio Cozzani and Martina Maurelli and Nello Tommasino and Stefano Caccavale and Luigi Gargiulo and Carlo Giovanni Carrera and Lidia Sacchelli and Caterina Longo and Sara Marchetti and Alessandra Michelucci and Dario Valguarnera and Andrea Carugno and Simone Mozzato and Francesca Lussana and Lorenzo Mercadante and Luca Cangialosi and Francesco Messina and Eugenia Veronica Di Brizzi and Matteo Bianco and Salvatore Scibetta and Chiara Assorgi and Marco Campoli and Rosa Giuseppa Angileri and Annunziata Dattola and Emanuele Trovato and Maria Esposito and Nicola Zerbinati and Claudio Guarneri and Francesco Loconsole and Valentina Dini and Anna Campanati and Claudia Lasagni and Federico Bardazzi and Angelo Valerio Marzano and Massimo Travaglini and Alessandra Narcisi and Anna Balato and Matteo Megna and Giampiero Girolomoni and Martina Burlando and Piergiorgio Malagoli and Simone Ribero and Diego Orsini},
  year = {2026},
  journal = {Dermatology and Therapy},
  doi = {10.1007/s13555-026-01925-5},
  url = {https://doi.org/10.1007/s13555-026-01925-5}
}

RIS

TY  - JOUR
TI  - Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis)
AU  - Luca Potestio
AU  - Salvatore Corrao
AU  - Luca Mastorino
AU  - Francesca Maria Gaiani
AU  - Emanuele Claudio Cozzani
AU  - Martina Maurelli
AU  - Nello Tommasino
AU  - Stefano Caccavale
AU  - Luigi Gargiulo
AU  - Carlo Giovanni Carrera
AU  - Lidia Sacchelli
AU  - Caterina Longo
AU  - Sara Marchetti
AU  - Alessandra Michelucci
AU  - Dario Valguarnera
AU  - Andrea Carugno
AU  - Simone Mozzato
AU  - Francesca Lussana
AU  - Lorenzo Mercadante
AU  - Luca Cangialosi
AU  - Francesco Messina
AU  - Eugenia Veronica Di Brizzi
AU  - Matteo Bianco
AU  - Salvatore Scibetta
AU  - Chiara Assorgi
AU  - Marco Campoli
AU  - Rosa Giuseppa Angileri
AU  - Annunziata Dattola
AU  - Emanuele Trovato
AU  - Maria Esposito
AU  - Nicola Zerbinati
AU  - Claudio Guarneri
AU  - Francesco Loconsole
AU  - Valentina Dini
AU  - Anna Campanati
AU  - Claudia Lasagni
AU  - Federico Bardazzi
AU  - Angelo Valerio Marzano
AU  - Massimo Travaglini
AU  - Alessandra Narcisi
AU  - Anna Balato
AU  - Matteo Megna
AU  - Giampiero Girolomoni
AU  - Martina Burlando
AU  - Piergiorgio Malagoli
AU  - Simone Ribero
AU  - Diego Orsini
PY  - 2026
JO  - Dermatology and Therapy
DO  - 10.1007/s13555-026-01925-5
UR  - https://doi.org/10.1007/s13555-026-01925-5
ER  -

APA

Potestio, L., Corrao, S., Mastorino, L., Gaiani, F. M., Cozzani, E. C., Maurelli, M., Tommasino, N., Caccavale, S., Gargiulo, L., Carrera, C. G., Sacchelli, L., Longo, C., Marchetti, S., Michelucci, A., Valguarnera, D., Carugno, A., Mozzato, S., Lussana, F., Mercadante, L., Cangialosi, L., Messina, F., Brizzi, E. V. D., Bianco, M., Scibetta, S., Assorgi, C., Campoli, M., Angileri, R. G., Dattola, A., Trovato, E., Esposito, M., Zerbinati, N., Guarneri, C., Loconsole, F., Dini, V., Campanati, A., Lasagni, C., Bardazzi, F., Marzano, A. V., Travaglini, M., Narcisi, A., Balato, A., Megna, M., Girolomoni, G., Burlando, M., Malagoli, P., Ribero, S., & Orsini, D. (2026). Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis). Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01925-5

Source records

crossref · retrieved 2026-09-25T11:46:36.987Z